REGENCY CENTERS CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that REGENCY CENTERS CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.55B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.45B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.32B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.22B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $1.17B | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $258.46M | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | $242.94M | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | $231.11M | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | $283.66M | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | $288.73M | Feb 17, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $527.46M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $400.39M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $364.56M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $482.87M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $361.41M | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $38.49M | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | $12.69M | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | $19.05M | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | ($25.33M) | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | $40.29M | Feb 17, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.12B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.05B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $951.29M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $896.79M | Feb 14, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $827.69M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $790.20M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $719.59M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $655.82M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $659.39M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $499.12M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $621.27M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $610.33M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $469.78M | Feb 18, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.00B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $12.39B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $12.43B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $10.86B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $10.79B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $10.94B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $11.13B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $10.94B | Feb 18, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.82B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $5.49B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $5.23B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $4.68B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $4.68B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $4.88B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $4.84B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $4.49B | Feb 18, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.91B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $6.72B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $7.03B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $6.10B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $6.04B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $5.98B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $6.21B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $6.40B | Feb 18, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $166.74M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $166.74M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $167.06M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $167.06M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $167.10M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $173.87M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $307.43M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $314.14M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $331.88M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $0 | Feb 21, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.74B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $4.41B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $4.15B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $3.73B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $3.72B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $3.92B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $3.92B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $3.72B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $3.59B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $1.64B | Feb 27, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | 0 | Feb 18, 2016 |
| FY2015 | Sep 30, 2015 | 0 | Feb 18, 2016 |
| FY2015 | Jun 30, 2015 | 0 | Feb 18, 2016 |
| FY2015 | Mar 31, 2015 | 0 | Feb 18, 2016 |
| FY2015 | Dec 31, 2014 | 0 | Feb 18, 2016 |
| FY2015 | Sep 30, 2014 | 0 | Feb 18, 2016 |
| FY2015 | Jun 30, 2014 | 0 | Feb 18, 2016 |
| FY2015 | Mar 31, 2014 | 0 | Feb 18, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Feb 20, 2015 |
| FY2014 | Sep 30, 2013 | 0 | Feb 20, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 0 | Feb 21, 2019 |
| FY2018 | Sep 30, 2018 | 0 | Feb 21, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Feb 21, 2019 |
| FY2018 | Mar 31, 2018 | 0 | Feb 21, 2019 |
| FY2017 | Dec 31, 2017 | 0 | Feb 27, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Feb 27, 2018 |
| FY2017 | Jun 30, 2017 | 0 | Feb 27, 2018 |
| FY2017 | Mar 31, 2017 | 0 | Feb 27, 2018 |
| FY2016 | Dec 31, 2016 | 0 | Feb 27, 2017 |
| FY2016 | Sep 30, 2016 | 0 | Feb 27, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 182.90M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 181.36M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | 184.58M | Feb 14, 2025 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $511.56M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $490.37M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $453.07M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $428.28M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $403.09M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $300.54M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $390.60M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $375.98M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $322.65M | Feb 18, 2020 |